ProfileGDS4459 / ENSG00000198805
TitleIntraportal tacrolimus flushing effect on liver allograft
OrganismHomo sapiens


flushed with tacrolimus flushed with albumin control GSM623464 GSM623465 GSM623466 GSM623467 GSM623468 GSM623469 GSM623470 GSM623471 GSM623472 GSM623473 GSM623474 GSM623475 GSM623476 GSM623477 GSM623478 GSM623479 GSM623480 82% 71% 94% 79% 87% 82% 96% 84% 92% 94% 79% 87% 89% 68% 94% 86% 82% sort by protocol Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM623464group A, liver allograft wedge biopsie tacrolimus treatment 16.1682
GSM623465group A, liver allograft wedge biopsie tacrolimus treatment 25.2771
GSM623466group A, liver allograft wedge biopsie tacrolimus treatment 3894
GSM623467group A, liver allograft wedge biopsie tacrolimus treatment 45.7479
GSM623468group A, liver allograft wedge biopsie tacrolimus treatment 56.9887
GSM623469group A, liver allograft wedge biopsie tacrolimus treatment 66.2682
GSM623470group A, liver allograft wedge biopsie tacrolimus treatment 78.4496
GSM623471group A, liver allograft wedge biopsie tacrolimus treatment 86.6184
GSM623472group A, liver allograft wedge biopsie tacrolimus treatment 97.7492
GSM623473group A, liver allograft wedge biopsie tacrolimus treatment 107.8594
GSM623474group B, liver allograft wedge biopsie placebo treatment 16.0179
GSM623475group B, liver allograft wedge biopsie placebo treatment 26.9787
GSM623476group B, liver allograft wedge biopsie placebo treatment 37.289
GSM623477group B, liver allograft wedge biopsie placebo treatment 45.0768
GSM623478group B, liver allograft wedge biopsie placebo treatment 58.0794
GSM623479group B, liver allograft wedge biopsie placebo treatment 66.6186
GSM623480group B, liver allograft wedge biopsie placebo treatment 76.1482